)
)
Biodesix Investor Relations Material
Latest events
Q3 2024
Biodesix
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Biodesix Inc
Access all reports
Biodesix, Inc. acquires and operates diagnostic companies, as well as develops and commercializes diagnostic tests in the areas of lung cancer, malignancies, and other diseases. The company provides a multi-protein blood test, which includes Nodality gene mutational panel for use in non-small-cell lung cancer (NSCLC) patients; and Biodesix Lung Reflex testing platform that analyzes circulating tumor DNA in advanced stage NSCLC patients. Biodesix, Inc. was founded in 2002 and is based in Boulder, Colorado with additional offices in California and Germany.
Key slides for Biodesix Inc
TD Cowen 44th Annual Health Care Conference 2024
Biodesix Inc
TD Cowen 44th Annual Health Care Conference 2024
Biodesix Inc
Latest articles
)
Quartr Brings Stories Behind the Numbers to Light
Quartr simplifies access to IR material and puts qualitative insights and company narratives front and center.
3 Feb 2025
)
The Evolution of the IRO Role: Staying Informed and Strategic With Quartr Pro
Staying informed is critical for IROs. Quartr Pro simplifies gathering market insights and narrative positioning with unprecedented speed and precision.
3 Feb 2025
)
Mips: The Gore-Tex of Brain Protection
How Mips turned a critical safety flaw into a global success, redefining helmet protection with its technology and ingredient brand business model.
24 Jan 2025
Ticker symbol
BDSX
Country
🇺🇸 United States